Literature DB >> 33489611

Comparison of Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting.

Ratan Kumar1, Kheraj Mal2, Muhammad Khalid Razaq3, Mansoor Magsi4, Muhammad Khizar Memon5, Sidra Memon6, Sana Irfan6, Kanwal Bansari6, Basma Ali6, Amber Rizwan7.   

Abstract

Introduction Percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) are two common treatment options used in patients suffering from coronary artery disease. Selection and favorability of one over the other depend on individual clinical scenarios. The purpose of this study is to compare outcomes after treatment with PCI and CABG. Methods This longitudinal observational study was conducted from April 2018 to July 2019 in a cardiovascular unit of a tertiary care hospital. Participants who were eligible for revascularization were randomized either to receive stent (PCI) or surgery (CABG). Patients were then followed up for 12 months for the development of all-cause mortality and major adverse cardiovascular events (MACEs). Results At 12 months, patients randomized to the PCI group had an increased risk of repeat revascularization (21.3% vs. 7.4%; p = 0.007), whereas a similar number of patients in both groups died (3.8% vs. 3.7%), suffered myocardial infarction (7.6% vs. 5.6%), or had a cerebrovascular accident (3.8% vs. 2.8%). Conclusions This study showed that PCI had an increased risk of repeat revascularization compared to CABG. However, both had comparable significance in the development of MACEs. Nevertheless, there is a need for further study to better assess the outcomes of either, especially in the long run.
Copyright © 2020, Kumar et al.

Entities:  

Keywords:  coronary artery bypass grafting; myocardial infarction; percutaneous coronary intervention

Year:  2020        PMID: 33489611      PMCID: PMC7815293          DOI: 10.7759/cureus.12202

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  11 in total

Review 1.  Coronary artery bypass surgery provides long-term results superior to percutaneous coronary intervention.

Authors:  Franklin L Rosenfeldt; Mark D Wilson; Brian F Buxton; Silvana F Marasco
Journal:  Heart Lung Circ       Date:  2011-09-19       Impact factor: 2.975

2.  Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries.

Authors:  Stuart J Head; David R Holmes; Michael J Mack; Patrick W Serruys; Friedrich W Mohr; Marie-Claude Morice; Antonio Colombo; A Pieter Kappetein
Journal:  JACC Cardiovasc Interv       Date:  2012-06       Impact factor: 11.195

3.  In left main CAD, CABG reduced major adverse cardiac or cerebrovascular events at 5 years compared with PCI.

Authors:  Eric R Bates
Journal:  Ann Intern Med       Date:  2017-02-21       Impact factor: 25.391

Review 4.  Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients.

Authors:  Tullio Palmerini; Patrick Serruys; Arie Pieter Kappetein; Philippe Genereux; Diego Della Riva; Letizia Bacchi Reggiani; Evald Høj Christiansen; Niels R Holm; Leif Thuesen; Timo Makikallio; Marie Claude Morice; Jung-Min Ahn; Seung-Jung Park; Holger Thiele; Enno Boudriot; Mario Sabatino; Mattia Romanello; Giuseppe Biondi-Zoccai; Raphael Cavalcante; Joseph F Sabik; Gregg W Stone
Journal:  Am Heart J       Date:  2017-05-18       Impact factor: 4.749

5.  Patients with left main coronary artery disease: stent or surgery?

Authors:  Marie-Claude Morice
Journal:  Lancet       Date:  2020-01-18       Impact factor: 79.321

Review 6.  PCI and CABG for Treating Stable Coronary Artery Disease: JACC Review Topic of the Week.

Authors:  Torsten Doenst; Axel Haverich; Patrick Serruys; Robert O Bonow; Pieter Kappetein; Volkmar Falk; Eric Velazquez; Anno Diegeler; Holger Sigusch
Journal:  J Am Coll Cardiol       Date:  2019-03-05       Impact factor: 24.094

7.  Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial.

Authors:  Arie Pieter Kappetein; Ted E Feldman; Michael J Mack; Marie-Claude Morice; David R Holmes; Elisabeth Ståhle; Keith D Dawkins; Friedrich W Mohr; Patrick W Serruys; Antonio Colombo
Journal:  Eur Heart J       Date:  2011-06-22       Impact factor: 29.983

8.  Debate over patient-centered care: percutaneous coronary intervention or coronary artery bypass grafting?

Authors:  Michio Kawasuji
Journal:  Surg Today       Date:  2011-03-23       Impact factor: 2.549

9.  Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial.

Authors:  Paulo Cury Rezende; Whady Hueb; Cibele Larrosa Garzillo; Eduardo Gomes Lima; Alexandre Ciappina Hueb; José Antonio Franchini Ramires; Roberto Kalil Filho
Journal:  J Thorac Cardiovasc Surg       Date:  2012-08-31       Impact factor: 5.209

Review 10.  Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.

Authors:  Saswata Deb; Harindra C Wijeysundera; Dennis T Ko; Hideki Tsubota; Samantha Hill; Stephen E Fremes
Journal:  JAMA       Date:  2013-11-20       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.